CLINICAL_TRIALS
trial_result
· 2016-03-04
Clinical Trial Update: Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649) [Phase 1]
Summary
Phase 1 trial of MK-8242 alone and with cytarabine in adults with acute myeloid leukemia (AML) was terminated; results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Acute Myelogenous Leukemia (AML) | Phase 1 | Status: TERMINATED | Results posted: 2016-03-04